Enzo Biochem Appoints Carl W. Balezentis, Ph.D., President Of Enzo Life Sciences Subsidiary

12-Jun-2006

Enzo Biochem, Inc. announced the appointment of Carl W. Balezentis, Ph.D. to the newly created position of President of Enzo Life Sciences, Inc. Dr. Balezentis, a senior executive with 18 years experience in the life sciences industry, was CEO of Lark Technologies, Inc., prior to its acquisition by Genaissance Pharmaceuticals, Inc. Enzo Life Sciences, a wholly owned subsidiary of Enzo Biochem, develops, manufactures and markets biomedical research products, nonradioactive labeling and detection protocols, as well as reagents for molecular biology research, including microarray methodologies for both gene expression and genomic analysis applications.

After Lark Technologies' acquisition, Dr. Balezentis joined Genaissance (which itself was subsequently acquired) as Senior VP. He was responsible for the rapid integration of Lark's facilities in the US and UK into Genaissance, and developed sales and marketing strategies aimed at fully utilizing the resources of both companies and developing synergistic opportunities. He spent a total of five years with both companies.

Previously, Dr. Balezentis was Director of Business Development of the multi-million dollar Life Sciences Division of Sigma-Aldrich Inc, where he had global responsibility for developing, organizing and leading business development activities, after previously serving as VP Sales and Marketing of Genosys Biotechnologies, Inc., which was acquired by Sigma-Aldrich. He also served as Director of Marketing at Perceptive Scientific Instruments, Inc., acquired by International Remote Imaging Systems, and as Group Leader-Human Identity Products at Applied Biosystems, Inc. (now Applera Corporation).

Among other positions he has held, Dr. Balezentis was Director - Gene Identity at Promega Corporation, Chief Scientific Officer of Molecular Identity Testing, Inc.; and Scientific/Technical Director of Molecular Diagnostic Associates, Inc.

Dr. Balezentis holds a BS degree in Biology and a Ph.D. in Genetics from the University of Arizona, in Tucson, and a Post Doctoral Fellowship at M.D. Anderson Cancer Center, in Houston, TX. He was a co-founder and Board Member of the Human Identity Trade Association, in addition to chairing in 1992 and 1993 the International Symposium on Human Identity.

https://www.bionity.com/en/news/55432/enzo-biochem-appoints-carl-w-balezentis-ph-d-president-of-enzo-life-sciences-subsidiary.html